The store will not work correctly when cookies are disabled.
(R)-gamma-(2-methylbenzyl)-L-proline Hydrochloride
ID: ALA4083473
Cas Number: 1049734-41-9
PubChem CID: 2761991
Max Phase: Preclinical
Molecular Formula: C13H18ClNO2
Molecular Weight: 219.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccccc1C[C@H]1CN[C@H](C(=O)O)C1.Cl
Standard InChI: InChI=1S/C13H17NO2.ClH/c1-9-4-2-3-5-11(9)6-10-7-12(13(15)16)14-8-10;/h2-5,10,12,14H,6-8H2,1H3,(H,15,16);1H/t10-,12+;/m1./s1
Standard InChI Key: SAHJHZDLFHMZMC-IYJPBCIQSA-N
Molfile:
RDKit 2D
17 17 0 0 0 0 0 0 0 0999 V2000
11.0315 -10.2626 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.9728 -11.8710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6433 -12.3578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3075 -11.8631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0426 -11.0780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2205 -11.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0896 -12.1093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2672 -12.9105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6988 -11.5543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7347 -10.4242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1280 -9.6986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9533 -9.6812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3470 -8.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9151 -8.2517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0859 -8.2764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6964 -9.0015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8765 -9.0268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 2 1 0
4 7 1 1
7 8 2 0
7 9 1 0
6 10 1 6
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
16 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 219.28 | Molecular Weight (Monoisotopic): 219.1259 | AlogP: 1.60 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.33 | Molecular Species: ZWITTERION | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.20 | CX Basic pKa: 11.49 | CX LogP: -0.11 | CX LogD: -0.11 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.81 | Np Likeness Score: 0.33 |
References
1. (2014) D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders, |
2. Singh K, Tanui R, Gameiro A, Eisenberg G, Colas C, Schlessinger A, Grewer C.. (2017) Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2., 27 (3): [PMID:28057420] [10.1016/j.bmcl.2016.12.063] |